BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The specific primary objective of this study is to determine whether rituximab is a safe and beneficial therapeutic for Myasthenia Gravis (MG) that warrants further study in a phase III efficacy trial.
Epistemonikos ID: e10b5139d18a9ea25c6c0923c1b2819b24ded532
First added on: May 11, 2024